Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/10923
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Apa, Ferda | - |
dc.contributor.author | Ate?ci, F.Ç. | - |
dc.contributor.author | Varma, G.S. | - |
dc.date.accessioned | 2019-08-16T13:33:55Z | |
dc.date.available | 2019-08-16T13:33:55Z | |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1302-0099 | - |
dc.identifier.uri | https://hdl.handle.net/11499/10923 | - |
dc.identifier.uri | https://doi.org/10.5505/kpd.2018.19970 | - |
dc.description.abstract | Valproic acid (VPA) is commonly used drug to treat variety of anticonvulsant and mood stabilizer in psychiatric and neurologic cases. It is thought to be a safe drug with a large therapeutic aspect..Uncommonly, hyperammonemia can be progressed by the usage of valproate and VPA induced hyperammonemia delirium-like condition by extrahepatic origin can be constituted. Being unrecognized of this situation in a timely manner can result in encephalopathy and even death. The measurement of the level of ammonia is important to establish a potentially lethal but reversible situation. In this case study, it is aimed that to present hyperammonemia related to the use of psychotropic drugs and to present a patient with hyperammonemia during VPA and antipsychotic use without a medical disease except bipolar disorder in the past. © 2018 ANP Publishing. All rights reserved. | en_US |
dc.language.iso | tr | en_US |
dc.publisher | ANP Publishing | en_US |
dc.relation.ispartof | Klinik Psikiyatri Dergisi | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Hyperammonemia | en_US |
dc.subject | Non-hepatic encephalopathy | en_US |
dc.subject | Valproic acid | en_US |
dc.title | Valproic acid induced hyperammonemic encephalopathy: A case report | en_US |
dc.type | Editorial | en_US |
dc.identifier.volume | 21 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 102 | |
dc.identifier.startpage | 102 | en_US |
dc.identifier.endpage | 106 | en_US |
dc.identifier.doi | 10.5505/kpd.2018.19970 | - |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.scopus | 2-s2.0-85045298682 | en_US |
dc.identifier.wos | WOS:000432255900012 | en_US |
dc.identifier.scopusquality | Q4 | - |
dc.owner | Pamukkale University | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | tr | - |
item.grantfulltext | open | - |
item.openairetype | Editorial | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Valproik Asit.pdf | 72.21 kB | Adobe PDF | View/Open |
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.